What Your Dog's Kidney Numbers Actually Mean at Each Stage of Disease

A creatinine value on a lab report rarely means much to a pet owner staring at it for the first time. Maybe your veterinarian mentioned a word like "azotemia," or handed you a printout with an SDMA result circled, and now you're trying to figure out whether this is an emergency, a slow-moving concern, or somewhere in between. Chronic kidney disease in dogs doesn't announce itself with a single diagnosis moment — it unfolds across a spectrum, and where your dog sits on that spectrum changes almost everything about the conversation that follows. Veterinary internal medicine specialists rely on a structured framework called IRIS staging to answer that question with more precision than a single blood value ever could. Understanding how that system works won't replace your veterinarian's judgment, but it will help you follow the reasoning behind the treatment plan, the recheck schedule, and the questions worth asking at your next appointment.

Why Kidney Disease Needs a Staging System at All

Dogs can lose a substantial portion of functioning kidney tissue before blood work shows anything abnormal. Creatinine, the molecule most commonly used to estimate kidney function, only rises once a large share of nephrons — the microscopic filtering units inside the kidney — have already stopped working. That delay creates a real clinical problem: by the time a standard blood panel flags a high creatinine, a dog may already have lost more kidney reserve than the number alone suggests.

This is precisely the gap the International Renal Interest Society, known as IRIS, set out to close. Formed by a board of veterinary nephrology specialists from multiple countries, IRIS built a staging framework so that a diagnosis of chronic kidney disease — once confirmed as persistent, not caused by dehydration or an unrelated illness, and not the result of a sudden acute injury — could be translated into a consistent, four-tier scale. That consistency matters practically. It lets your veterinarian compare today's lab work to results from six months ago in a meaningful way, and it gives a nephrology specialist or emergency clinic the same shared vocabulary if your dog is ever referred or needs urgent evaluation elsewhere.

It's worth being clear about what staging is not. IRIS staging is applied only after chronic kidney disease has already been diagnosed through history, physical exam, and lab findings — it is a classification tool for known, stable CKD, not a diagnostic test on its own, and it should not be applied to a dog whose kidney values are fluctuating rapidly, which usually points toward an acute injury rather than a chronic, slowly progressive disease.

The Four IRIS Stages, Explained Through Blood Creatinine and SDMA

Staging begins with two blood values, ideally checked together, on a fasted and adequately hydrated dog, and confirmed on at least two occasions rather than a single snapshot. The first is blood creatinine, the traditional marker. The second is SDMA (symmetric dimethylarginine), a newer biomarker that tends to rise earlier than creatinine because it isn't affected by muscle mass the way creatinine is — a detail that matters in older, thinner dogs whose declining muscle can artificially keep creatinine looking deceptively normal.

Under the current IRIS framework, Stage 1 describes dogs with normal or only mildly elevated creatinine, generally under 1.4 mg/dL, alongside an SDMA typically below 18 µg/dL. A dog can still land in Stage 1 even with normal blood values if another sign of kidney abnormality is present, such as inappropriate urine concentration, protein in the urine, or abnormal kidney imaging findings. Stage 2 covers mild renal azotemia, with creatinine generally in the 1.4–2.8 mg/dL range and SDMA between roughly 18 and 35 µg/dL; clinical signs at this point are usually mild or entirely absent, which is part of why routine senior bloodwork matters even in dogs that seem outwardly healthy.

Stage 3 reflects moderate azotemia, with creatinine climbing to roughly 2.9–5.0 mg/dL and SDMA in the 36–54 µg/dL range. This is often where extrarenal signs start becoming noticeable — appetite changes, weight loss, or increased lethargy — though IRIS itself notes that Stage 3 spans a wide range, from dogs with few symptoms to dogs with marked systemic illness. Stage 4 marks severe renal azotemia, with creatinine above 5.0 mg/dL and SDMA typically exceeding 54 µg/dL, carrying a substantially increased risk of uremic crisis, where toxin buildup begins to affect multiple organ systems at once.

One detail that surprises many owners: if a dog's creatinine and SDMA point to different stages, IRIS guidance directs veterinarians to stage and treat according to the higher, more advanced value rather than averaging the two or waiting for confirmation. A creatinine reading that looks like early Stage 2, paired with a persistently elevated SDMA above 35 µg/dL, would push that dog's management into Stage 3 territory — because missing early kidney decline carries more risk than acting on it a little early.

Sub-Staging: Why Two Dogs in the Same Stage Can Need Different Plans

Stage number alone doesn't tell the whole story, and this is where a lot of home-researched understanding of kidney disease falls short. IRIS requires two additional layers of classification once a stage is assigned: how much protein is leaking into the urine, and what the dog's systemic blood pressure looks like. Both are independently damaging to kidney tissue, and both can occur at any stage of disease, sometimes together, sometimes alone.

Proteinuria is measured through a urine protein-to-creatinine ratio, commonly abbreviated UP/C, ideally confirmed across at least two urine samples collected over a couple of weeks rather than acted on from a single test. A UP/C below 0.2 is considered non-proteinuric, a result between 0.2 and 0.5 is classified as borderline proteinuric, and anything above 0.5 is classified as proteinuric in dogs. Protein loss through damaged kidney filters isn't just a marker of existing damage — persistent proteinuria is itself a recognized driver of further nephron loss, which is why veterinarians often treat it directly rather than simply monitoring it.

Blood pressure substaging follows a similar logic. Chronic kidney disease frequently disrupts the body's blood pressure regulation, and the resulting hypertension can silently damage the eyes, heart, and brain long before it damages the kidneys further. A systolic reading under 140 mmHg is considered normotensive with minimal risk of organ damage; 140–159 mmHg is prehypertensive with low risk; 160–179 mmHg is hypertensive with moderate risk; and readings at or above 180 mmHg are classified as severely hypertensive, carrying a high risk of damage to the eyes, heart, or brain. Because stress at a veterinary clinic can temporarily elevate blood pressure, IRIS recommends multiple readings, ideally across separate visits, before a hypertension substage is confirmed — one nervous appointment shouldn't permanently label a calm dog as hypertensive.

The table below summarizes how these three layers combine to describe a single dog's status, since a complete IRIS classification always includes all three components together rather than the stage number alone.

A dog described only as "Stage 2" is missing two-thirds of the clinical picture. A Stage 2 dog who is also proteinuric and severely hypertensive faces a meaningfully different trajectory, and likely a more assertive treatment plan, than a Stage 2 dog with normal blood pressure and no protein loss.

How Symptoms Track the Stage — And Why Stage 1 Dogs Often Look Fine

One of the more counterintuitive aspects of canine CKD is that dogs in the earliest stages frequently show nothing an owner would notice at home. Kidneys have substantial functional reserve, and Stage 1 or early Stage 2 dogs are typically maintaining normal or near-normal blood chemistry through compensation, sometimes revealing themselves only through subtly increased thirst, slightly larger urine volume, or dilute urine on a specific gravity test. These are easy signs to miss or attribute to summer heat, a diet change, or simply getting older.

By Stage 3, the kidneys' compensatory capacity starts to fail more visibly. This is generally where owners start noticing reduced appetite, occasional vomiting, weight loss, a dull coat, or increased lethargy, as uremic toxins that a healthy kidney would clear begin accumulating in the bloodstream. Stage 4 represents a more severe accumulation of those toxins, with a meaningfully higher risk of uremic crisis — a state where nausea, vomiting, oral ulcers, and profound weakness can develop, sometimes rapidly. A dog with sudden collapse, repeated vomiting that won't stop, difficulty breathing, pale gums, or an inability to urinate needs emergency veterinary attention immediately rather than a scheduled recheck, regardless of what stage was assigned previously — those signs can indicate a crisis that isn't waiting for the next appointment.

What Changes in the Treatment Conversation as Stages Progress

Chronic kidney disease is, by definition, not reversible — damaged nephrons don't regenerate, and no product or protocol restores lost kidney tissue. What does change stage by stage is the goal: preserving whatever function remains, slowing the pace of further decline, and controlling the downstream effects of reduced kidney function on the rest of the body.

In Stage 1 and early Stage 2, management tends to center on identifying and correcting any underlying or contributing cause, monitoring trends in creatinine and SDMA over time rather than reacting to a single value, and beginning conversations about kidney-supportive nutrition under veterinary guidance rather than jumping straight to a strict prescription renal diet. As dogs move into later Stage 2 and Stage 3, therapeutic renal diets — formulated with controlled and higher-quality protein, reduced phosphorus, and adjusted sodium — become a more central recommendation, alongside closer monitoring for proteinuria and hypertension that may now warrant direct treatment rather than observation. Hydration support, whether through encouraging water intake or, in some cases, subcutaneous fluids managed by a veterinary team, often enters the plan around this point as well.

Stage 3 and Stage 4 typically bring a broader set of tools into play: phosphate binders to manage the phosphorus retention that worsens as kidney function declines, blood pressure medications when hypertension substaging warrants it, and targeted management of uremic symptoms such as nausea or reduced appetite. None of these interventions are interchangeable between dogs, and none should be assembled independently of lab monitoring — a plan that made sense at last year's Stage 2 recheck may need real adjustment once new bloodwork places a dog in Stage 3, which is exactly why IRIS recommends revisiting staging and substaging at each significant recheck rather than treating it as a one-time label.

Where Supportive Products Fit, and Where They Don't

A meaningful expectation gap shows up here often: a supportive product, whether a kidney-support supplement or a nutritional aid, is not a substitute for staging, lab monitoring, or a prescription renal diet once one is indicated. Appetite improving after starting something new doesn't necessarily mean kidney values are improving — those are separate measurements, and only bloodwork and urine testing can confirm whether a treatment plan is actually slowing disease progression. Similarly, unverified herbal kidney "flushes" or unregulated protein-restricted home diets attempted without veterinary blood work carry real risk, particularly in Stage 3 or 4 dogs where nutrient balance has to be managed with precision rather than guesswork.

Where a resource like HERO Veterinary fits into this picture is as a source of category information and scientifically formulated support options that a pet owner can bring into a conversation with their veterinarian, alongside educational content that helps make sense of a diagnosis between appointments — not as a stand-in for the diagnostic workup itself. For readers exploring how supportive nutritional products are developed and validated for veterinary use, an overview of scientifically formulated supplements used in veterinary clinical settings walks through how such products are typically evaluated before being positioned as part of a broader care plan. Any supplement or supportive product, at any stage, works best as one piece of a plan your veterinarian is actively monitoring, not as a replacement for the recheck labs that actually track whether the disease is stable, slowing, or advancing.

Questions Worth Bringing to Your Next Recheck

Owners often leave a diagnosis appointment with a stage number but without a clear sense of what to ask next. It's reasonable to ask your veterinarian which specific stage and substage your dog currently falls into, what the UP/C and blood pressure results were at the last visit, how frequently rechecks are recommended given the current stage, and what specific changes — appetite, thirst, energy, vomiting — should prompt an earlier call rather than waiting for the scheduled recheck. It's also worth asking directly whether a prescription renal diet is indicated yet, since introducing one too early or too late relative to a dog's actual stage can affect its usefulness.

Because chronic kidney disease management is a long-term relationship rather than a single decision, understanding this framework tends to make owners better partners in that process, not more anxious participants in it. If you're weighing how a broader platform's resources and product categories fit alongside your veterinarian's plan, HERO Veterinary's about page outlines the organization's approach to supporting pet owners navigating chronic conditions like this one.